CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS

ECOA RESOURCES

ECONSENT RESOURCES

  • A top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.

  • Despite the rise of digital solutions in healthcare, paper consent forms are still common in today’s clinical trials. Unfortunately, these paper forms pose significant challenges in retaining the documentation of informed consent for centrally stored biospecimens.

  • Participant-focused eClinical technologies offer significant potential to decrease paper-based processes and improve end-user experiences in collecting patient-reported outcomes (PRO) and informed consent, but many users continue to experience rigid technology, complicated hardware provisioning processes, and clunky implementations that leave sponsors, CROs and sites questioning the value. 

EPRO RESOURCES

  • Participant-focused eClinical technologies offer significant potential to decrease paper-based processes and improve end-user experiences in collecting patient-reported outcomes (PRO) and informed consent, but many users continue to experience rigid technology, complicated hardware provisioning processes, and clunky implementations that leave sponsors, CROs and sites questioning the value. 

  • The shift from reporting on paper to reporting electronically has been happening for years, however, the transition hasn’t always been elegant. Explore how the pandemic has played a role in accelerating the shift to eCOA/ePRO.

  • Join our solutions experts as they demonstrate how Castor ePRO can enhance your clinical trial by improving the patient experience and streamlining site operations.